Thought I'd see if any of the authors of the linked paper have anything to do with Sepcell, the consortium set up to provide a new approach to the treatment of severe sepsis.
One name I found in the list of authors is the principal investigator within the Sepcell project, Dr. Tom van der Poll, professor of Medicine at the Academic Medical Center (AMC), Netherlands, Head of the Center of Experimental and Molecular Medicine and is the Chair of the Division of Infectious Diseases at AMC.
The AMC is the same institution the senior author of the study, Desirée Perlee, a doctoral candidate, is from. It looks to me as if this trial was a lead up to the clinical trial treating people with sepsis, see below.
The Sepcell consortium includes the now wholly owned subsidiary of Takeda, TiGenix.
For info on how Sepcell see MSCs function treating sepsis have a read of their undated public summary. Sepsis itself sounds very nasty stuff and and is one of the leading causes of mortality in the intensive care units in the developed world.
The phase Ib/IIa clinical trial treated the first enrolled sepsis patients early this year so it will be a while before results are published.
@stokdog it will be really good if this does go on to show
The power of MSC'S
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-186
-
- There are more pages in this discussion • 17,850 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
93.5¢ |
Change
0.020(2.19%) |
Mkt cap ! $1.067B |
Open | High | Low | Value | Volume |
92.0¢ | 94.5¢ | 92.0¢ | $1.622M | 1.742M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 64563 | 93.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.0¢ | 204239 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 64563 | 0.930 |
6 | 79973 | 0.925 |
13 | 254982 | 0.920 |
11 | 107275 | 0.915 |
4 | 115328 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.940 | 204239 | 3 |
0.945 | 22942 | 2 |
0.950 | 91123 | 5 |
0.955 | 42425 | 1 |
0.960 | 61820 | 3 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |